Finland· FI-REL-REL36679
Teysuno
A tegafur, kombinationen product containing tegafur + gimeracil + oteracil potassium, registered in Finland by Nordic Group BV. The same ATC class is registered in 9 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Tegafur, kombinationen is registered in 9 of 19 countries.
Countries holding a registration under ATC L01BC53 (tegafur, kombinationen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Tegafur, kombinationen · ATC L01BC53
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Tegafur + Gimeracil + Oteracil potassium
- Manufacturer
- Nordic Group BV
- Country
- Finland (FI)
- ATC code
- L01BC53
- ATC class
- Tegafur, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tegafur, kombinationen in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaTEYSUNONordic Group BV, Hoofddorp
- SpainTEYSUNO 15 mg/4,35 mg/11,8 mg CAPSULAS DURASNordic Group B.V.
- IrelandTeysuno 15 mg/4.35 mg/11.8 mg hard capsulesNordic Group B.V.
- IcelandTeysunoNordic Group BV
- NetherlandsTeysuno 15 mg/4,35 mg/11,8 mg harde capsulesNordic Group BV
- NorwayTeysunoNordic Group BV
- PolandTeysunoNordic Group B.V.
- SwedenTeysuno 15 mg/4,35 mg/11,8 mg Kapsel, hårdNordic Group BV
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Teysuno
- Iceland · Teysuno
- Liechtenstein · Teysuno
- Norway · Teysuno
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/32a1c418-9c45-4a2b-a6d9-18be665aeb5d GET /v1/drugs/32a1c418-9c45-4a2b-a6d9-18be665aeb5d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "kapseli, kova",
"route": "Suun kautta",
"ddd_unit": null,
"strength": "20 mg / 5.8 mg / 15.8 mg",
"atc_label": "tegafuuri, yhdistelmävalmisteet",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/11/669/003-004",
"fimea_rel_id": "REL36679",
"authorised_at": "2011-03-14"
}See everything about tegafur, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.